Correlation Between Helvetia Holding and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Helvetia Holding and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Helvetia Holding and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Helvetia Holding AG and BB Biotech AG, you can compare the effects of market volatilities on Helvetia Holding and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Helvetia Holding with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Helvetia Holding and BB Biotech.

Diversification Opportunities for Helvetia Holding and BB Biotech

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Helvetia and BION is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Helvetia Holding AG and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Helvetia Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Helvetia Holding AG are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Helvetia Holding i.e., Helvetia Holding and BB Biotech go up and down completely randomly.

Pair Corralation between Helvetia Holding and BB Biotech

Assuming the 90 days trading horizon Helvetia Holding AG is expected to generate 0.84 times more return on investment than BB Biotech. However, Helvetia Holding AG is 1.19 times less risky than BB Biotech. It trades about 0.08 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.04 per unit of risk. If you would invest  9,762  in Helvetia Holding AG on August 29, 2024 and sell it today you would earn a total of  5,428  from holding Helvetia Holding AG or generate 55.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Helvetia Holding AG  vs.  BB Biotech AG

 Performance 
       Timeline  
Helvetia Holding 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Helvetia Holding AG are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Helvetia Holding may actually be approaching a critical reversion point that can send shares even higher in December 2024.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Helvetia Holding and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Helvetia Holding and BB Biotech

The main advantage of trading using opposite Helvetia Holding and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Helvetia Holding position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind Helvetia Holding AG and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum